SCHEMBL4733923

SCHEMBL4733923

N#Cc1cccc(-c2cc3c(c(C(=O)O)c2)OCCO3)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 4/20 0.53
SLC22A12 Q96S37 3/20 0.53
GSK3A P49840 2/20 0.43
GSK3B P49841 2/20 0.43
IKBKB O14920 1/20 0.43
CHUK O15111 1/20 0.43
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTT P42858 1/20 0.40
F11 P03951 1/20 0.39
PIN1 Q13526 1/20 0.39
NOTUM Q6P988 2/20 0.38
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
KAT6A Q92794 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4734731 0.86 XDH (0.46) XDHSLC22A12GSK3AGSK3BNPC1
SCHEMBL4735875 0.84 ACMSD (0.50) NPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL4739410 0.84 XDH (0.53) XDHSLC22A12GSK3BIKBKBCHUK
SCHEMBL4738778 0.82 MMP3 (0.45) XDHALDH1A1
SCHEMBL4736975 0.82 DHODH (0.43) NPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL4737367 0.81 ACMSD (0.47) NPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL4737775 0.81 CTNNB1 (0.49) NPC1ALDH1A1RAB9ASMN1; SMN2PIN1
SCHEMBL4735827 0.81 MCL1 (0.54) NPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL4736941 0.81 DCLRE1B (0.46) IKBKBCHUKNPC1ALDH1A1RAB9A
SCHEMBL4735844 0.81 AKR1C2 (0.52) NPC1ALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-08-28 US claimed
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-08-28 US disclosed
WO-2008071455-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS FSHR, GNRHR, TPH1 XDH 2848/4885SLC22A12 2654/4885GSK3A 4656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.